Skip to content
Screener

OrthoPediatrics KIDS Income Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$70.51M+15.4%$59.36M+13.3%$61.61M+17.0%$61.25M+12.2%$61.08M+15.7%
$18.14M+6.3%$15.97M+12.9%$16.5M-3.5%$15.98M+10.1%$17.06M+42.2%
$52.37M+19.0%$43.39M+13.4%$45.11M+26.8%$45.27M+13.0%$44.02M+7.9%
74.3%+2.2pp73.1%+0.1pp73.2%+5.7pp73.9%+0.5pp72.1%-5.2pp
$2.33M+7.7%$2.23M-5.1%$2.26M-22.5%$2.33M-9.5%$2.16M-15.1%
$21.29M+11.5%$18.47M+11.5%$18.4M+9.6%$18.65M+11.4%$19.1M+15.1%
$32.81M+7.8%$31.02M+2.5%$29.95M+22.6%$29.16M+10.9%$30.44M+11.4%
$56.43M+3.2%$51.73M+5.0%$53.28M+7.4%$54.7M+19.9%$54.68M+17.7%
-$4.07M+61.8%-$8.34M+24.1%-$8.17M+41.9%-$9.43M-69.4%-$10.66M-88.1%
-5.8%+11.7pp-14%+6.9pp-13.3%+13.4pp-15.4%-5.2pp-17.4%-6.7pp
$2.53M+127%$2.1M+86.7%$1.93M+46.5%$1.82M+351%$1.12M+328%
-$2.86M-180%-$2.52M-587%-$2.47M+30.8%$3.59M+1,043%
-$6.93M+1.9%-$10.86M-3.8%-$9.76M+40.5%-$11.9M-30.2%-$7.06M-16.8%
$234K+378%-$171K-187%$340K+200%-$125K+89.7%$49K+372%
-$7.16M-0.7%-$10.69M-0.3%-$10.1M+37.1%-$11.77M-48.7%-$7.11M-18.0%
-10.2%+1.5pp-18%+2.3pp-16.4%+14.1pp-19.2%-4.7pp-11.6%-0.2pp
-$0.300.0%-$0.45+2.2%-$0.43+38.6%-$0.50-47.1%-$0.30-15.4%
$1.64M+130%-$2.61M+55.9%-$2.57M+74.5%-$4.13M-1,344%-$5.49M-519%
2.3%+11.3pp-4.4%+6.9pp-4.2%+14.9pp-6.7%-6.2pp-9%-7.3pp
-$4.07M+61.8%-$8.34M+24.1%-$8.17M+41.9%-$9.43M-69.4%-$10.66M-88.1%

FAQ

What is OrthoPediatrics's revenue?
OrthoPediatrics (KIDS) generated $252.7M in revenue over the trailing twelve months, up 14.5% year over year.
Is OrthoPediatrics profitable?
OrthoPediatrics is not currently profitable: it reported a net loss of $39.7M over the trailing twelve months, a -15.7% net margin.
What are OrthoPediatrics's profit margins?
Gross margin is 73.7% and operating margin is -11.9%, with a -15.7% net margin.
What is OrthoPediatrics's earnings per share?
OrthoPediatrics's diluted EPS over the trailing twelve months is $-1.68.
Where does OrthoPediatrics's income statement data come from?
Every line is extracted from OrthoPediatrics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.